Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Increase (Decrease) in Employee Related Liabilities

2.8 / 5 stars · 68/120 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Employee Related Liabilities

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Employee Related Liabilities of -$64.86 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-27 was $18.90M, a 20.34% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-28 was -$83.76M, a 648.76% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-27 was -$2.56M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-27 was $42.88M, a 37.56% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for fiscal 2025 was $79.31M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for fiscal 2024 was -$27.60M, a 321.77% decline from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for fiscal 2023 was $12.45M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in employee related liabilities for fiscal 2022 was -$42.16M, a 195.17% decline from fiscal 2021.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 6 month as first filedIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 9 month as first filedIncrease (Decrease) in Employee Related Liabilities 12 month
2026-06-27$18.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$64.86M
10-Q · filed 2026-08-05
-$67.42M
derived: sum of 3 quarters · filed 2026-08-05
-$24.54M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28-$83.76M
10-Q · filed 2026-05-07
-$86.32M
derived: sum of 2 quarters · filed 2026-05-07
-$43.44M
derived: sum of 3 quarters · filed 2026-05-07
-$19.71M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-27-$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$40.32M
derived: sum of 2 quarters · filed 2026-02-18
$64.05M
derived: sum of 3 quarters · filed 2026-08-05
$79.31M
10-K · filed 2026-02-18
2025-09-27$42.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$66.61M
derived: sum of 2 quarters · filed 2026-08-05
$81.87M
10-Q · filed 2025-11-05
$56.25M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28$23.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$38.99M
10-Q · filed 2026-08-05
$13.37M
derived: sum of 3 quarters · filed 2026-08-05
$44.54M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$15.26M
10-Q · filed 2026-05-07
-$10.36M
derived: sum of 2 quarters · filed 2026-05-07
$20.81M
derived: sum of 3 quarters · filed 2026-05-07
$8.60M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-28-$25.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$5.55M
derived: sum of 2 quarters · filed 2026-02-18
-$6.66M
derived: sum of 3 quarters · filed 2026-02-18
-$27.60M
10-K · filed 2026-02-18
2024-09-28$31.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$18.96M
derived: sum of 2 quarters · filed 2025-11-05
-$1.98M
10-Q · filed 2025-11-05
-$17.97M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-29-$12.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$33.15M
10-Q · filed 2025-08-06
-$49.14M
derived: sum of 3 quarters · filed 2026-02-18
-$13.06M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-30-$20.95M
10-Q · filed 2025-05-07
-$36.94M
derived: sum of 2 quarters · filed 2026-02-18
-$850.00K
derived: sum of 3 quarters · filed 2026-02-18
$12.97M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-30-$15.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$20.09M
derived: sum of 2 quarters · filed 2026-02-18
$33.92M
derived: sum of 3 quarters · filed 2026-02-18
$12.45M
10-K · filed 2026-02-18
2023-09-30$36.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$49.91M
derived: sum of 2 quarters · filed 2024-11-06
$28.44M
10-Q · filed 2024-11-06
$19.01M
derived: sum of 4 quarters · filed 2025-02-19
2023-07-01$13.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$7.65M
10-Q · filed 2024-08-07
-$17.08M
derived: sum of 3 quarters · filed 2025-02-19
-$11.64M
derived: sum of 4 quarters · filed 2025-02-19
2023-04-01-$21.47M
10-Q · filed 2024-05-09
-$30.90M
derived: sum of 2 quarters · filed 2025-02-19
-$25.46M
derived: sum of 3 quarters · filed 2025-02-19
$16.16M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31-$9.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
-$3.99M
derived: sum of 2 quarters · filed 2025-02-19
$37.63M
derived: sum of 3 quarters · filed 2025-02-19
-$42.16M
10-K · filed 2025-02-19
2022-09-24$5.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$47.06M
derived: sum of 2 quarters · filed 2023-11-08
-$32.73M
10-Q · filed 2023-11-08
-$6.64M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-25$41.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$38.17M
10-Q · filed 2023-08-09
-$12.08M
derived: sum of 3 quarters · filed 2024-02-14
-$7.80M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-26-$79.80M
10-Q · filed 2023-05-11
-$53.70M
derived: sum of 2 quarters · filed 2024-02-14
-$49.42M
derived: sum of 3 quarters · filed 2024-02-14
$1.87M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-25$26.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$30.37M
derived: sum of 2 quarters · filed 2024-02-14
$81.66M
derived: sum of 3 quarters · filed 2024-02-14
$44.30M
10-K · filed 2024-02-14
2021-09-25$4.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$55.57M
derived: sum of 2 quarters · filed 2022-11-02
$18.21M
10-Q · filed 2022-11-02
$29.25M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-26$51.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$13.93M
10-Q · filed 2022-08-03
$24.98M
derived: sum of 3 quarters · filed 2023-02-22
$45.69M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-27-$37.36M
10-Q · filed 2022-05-04
-$26.32M
derived: sum of 2 quarters · filed 2023-02-22
-$5.61M
derived: sum of 3 quarters · filed 2023-02-22
$48.37M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-26$11.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$31.75M
derived: sum of 2 quarters · filed 2023-02-22
$85.73M
derived: sum of 3 quarters · filed 2023-02-22
$40.48M
10-K · filed 2023-02-22
2020-09-26$20.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$74.68M
derived: sum of 2 quarters · filed 2021-11-03
$29.44M
10-Q · filed 2021-11-03
$56.15M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-27$53.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$8.73M
10-Q · filed 2021-08-04
$35.44M
derived: sum of 3 quarters · filed 2022-02-16
$37.54M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-28-$45.24M
10-Q · filed 2021-05-04
-$18.53M
derived: sum of 2 quarters · filed 2022-02-16
-$16.43M
derived: sum of 3 quarters · filed 2022-02-16
$13.26M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-28$26.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$28.82M
derived: sum of 2 quarters · filed 2022-02-16
$58.51M
derived: sum of 3 quarters · filed 2022-02-16
$3.39M
10-K · filed 2022-02-16
2019-09-28$2.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$31.79M
derived: sum of 2 quarters · filed 2020-10-29
-$23.32M
10-Q · filed 2020-10-29
$2.21M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29$29.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$25.42M
10-Q · filed 2020-08-05
$107.00K
derived: sum of 3 quarters · filed 2021-02-17
$8.61M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30-$55.11M
10-Q · filed 2020-05-07
-$29.59M
derived: sum of 2 quarters · filed 2021-02-17
-$21.08M
derived: sum of 3 quarters · filed 2021-02-17
$7.49M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29$25.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$34.03M
derived: sum of 2 quarters · filed 2021-02-17
$62.61M
derived: sum of 3 quarters · filed 2021-02-17
$31.62M
10-K · filed 2021-02-17
2018-09-29$8.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$37.08M
derived: sum of 2 quarters · filed 2019-11-06
$6.09M
10-Q · filed 2019-11-06
$20.30M
derived: sum of 4 quarters · filed 2020-02-11
2018-06-30$28.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
-$2.42M
10-Q · filed 2019-07-31
$11.80M
derived: sum of 3 quarters · filed 2020-02-11
$11.96M
derived: sum of 4 quarters · filed 2020-02-11
2018-03-31-$30.99M
10-Q · filed 2019-05-07
-$16.78M
derived: sum of 2 quarters · filed 2020-02-11
-$16.61M
derived: sum of 3 quarters · filed 2020-02-11
$3.07M
derived: sum of 4 quarters · filed 2020-02-11
2017-12-30$14.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11
$14.38M
derived: sum of 2 quarters · filed 2020-02-11
$34.06M
derived: sum of 3 quarters · filed 2020-02-11
$3.67M
10-K · filed 2020-02-11
2017-09-30$167.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$19.85M
derived: sum of 2 quarters · filed 2018-11-07
-$10.55M
10-Q · filed 2018-11-07
-$9.41M
derived: sum of 4 quarters · filed 2019-02-13
2017-07-01$19.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
-$10.71M
10-Q · filed 2018-08-08
-$9.58M
derived: sum of 3 quarters · filed 2019-02-13
$2.83M
derived: sum of 4 quarters · filed 2019-02-13
2017-04-01-$30.40M
10-Q · filed 2018-05-10
-$29.26M
derived: sum of 2 quarters · filed 2019-02-13
-$16.86M
derived: sum of 3 quarters · filed 2019-02-13
-$5.08M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$13.54M
derived: sum of 2 quarters · filed 2019-02-13
$25.32M
derived: sum of 3 quarters · filed 2019-02-13
$9.30M
10-K · filed 2019-02-13
2016-09-24$12.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$24.19M
derived: sum of 2 quarters · filed 2017-11-09
$8.16M
10-Q · filed 2017-11-09
$14.34M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-25$11.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$4.24M
10-Q · filed 2017-08-09
$1.93M
derived: sum of 3 quarters · filed 2018-02-13
$16.93M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-26-$16.02M
10-Q · filed 2017-05-10
-$9.85M
derived: sum of 2 quarters · filed 2018-02-13
$5.15M
derived: sum of 3 quarters · filed 2018-02-13
$9.64M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-26$6.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$21.17M
derived: sum of 2 quarters · filed 2018-02-13
$25.67M
derived: sum of 3 quarters · filed 2018-02-13
$8.41M
10-K · filed 2018-02-13
2015-09-26$14.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$19.49M
derived: sum of 2 quarters · filed 2016-11-02
$2.24M
10-Q · filed 2016-11-02
$5.07M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-27$4.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
-$12.76M
10-Q · filed 2016-08-03
-$9.92M
derived: sum of 3 quarters · filed 2017-02-14
$2.10M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-28-$17.25M
10-Q · filed 2016-05-04
-$14.42M
derived: sum of 2 quarters · filed 2017-02-14
-$2.39M
derived: sum of 3 quarters · filed 2017-02-14
$2.22M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-27$2.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$14.86M
derived: sum of 2 quarters · filed 2017-02-14
$19.47M
derived: sum of 3 quarters · filed 2017-02-14
$13.63M
10-K · filed 2017-02-14
2014-09-27$12.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$16.63M
derived: sum of 2 quarters · filed 2015-11-04
$10.79M
10-Q · filed 2015-11-04
$12.22M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-28$4.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
-$1.23M
10-Q · filed 2015-07-30
$197.00K
derived: sum of 3 quarters · filed 2016-02-12
$11.83M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-29-$5.84M
10-Q · filed 2015-04-30
-$4.41M
derived: sum of 2 quarters · filed 2016-02-12
$7.22M
derived: sum of 3 quarters · filed 2016-02-12
$8.74M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-28$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$13.06M
derived: sum of 2 quarters · filed 2016-02-12
$14.58M
derived: sum of 3 quarters · filed 2016-02-12
$11.93M
10-K · filed 2016-02-12
2013-09-28$11.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$13.15M
derived: sum of 2 quarters · filed 2014-10-30
$10.50M
10-Q · filed 2014-10-30
$8.82M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-29$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$1.14M
10-Q · filed 2014-08-07
-$2.81M
derived: sum of 3 quarters · filed 2015-02-17
$7.37M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-30-$2.65M
10-Q · filed 2014-04-30
-$4.33M
derived: sum of 2 quarters · filed 2015-02-17
$5.85M
derived: sum of 3 quarters · filed 2015-02-17
$3.62M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-29-$1.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
$8.50M
derived: sum of 2 quarters · filed 2015-02-17
$6.27M
derived: sum of 3 quarters · filed 2015-02-17
$4.61M
10-K · filed 2015-02-17
2012-09-29$10.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$7.95M
derived: sum of 2 quarters · filed 2013-10-30
$6.29M
10-Q · filed 2013-10-30
$4.02M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30-$2.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31
-$3.89M
10-Q · filed 2013-07-31
-$6.16M
derived: sum of 3 quarters · filed 2014-02-25
-$14.73M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$1.66M
10-Q · filed 2013-05-08
-$3.93M
derived: sum of 2 quarters · filed 2014-02-25
-$12.50M
derived: sum of 3 quarters · filed 2014-02-25
-$4.88M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31-$2.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
-$10.84M
derived: sum of 2 quarters · filed 2014-02-25
-$3.22M
derived: sum of 3 quarters · filed 2014-02-25
-$7.41M
10-K · filed 2014-02-25
2011-09-24-$8.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
-$955.00K
derived: sum of 2 quarters · filed 2012-11-01
-$5.14M
10-Q · filed 2012-11-01
-$1.68M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-25$7.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$3.43M
10-Q · filed 2012-08-07
$6.90M
derived: sum of 3 quarters · filed 2013-02-27
$2.21M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-26-$4.19M
10-Q · filed 2012-05-04
-$721.00K
derived: sum of 2 quarters · filed 2013-02-27
-$5.41M
derived: sum of 3 quarters · filed 2013-02-27
$1.04M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-25$3.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
-$1.22M
derived: sum of 2 quarters · filed 2013-02-27
$5.23M
derived: sum of 3 quarters · filed 2013-02-27
$4.48M
10-K · filed 2013-02-27
2010-09-25-$4.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$1.76M
derived: sum of 2 quarters · filed 2011-11-02
$1.01M
10-Q · filed 2011-11-02
$893.00K
10-Q · filed 2010-11-04
$5.24M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-26$6.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03
$5.70M
10-Q · filed 2011-08-03
$5.60M
10-Q · filed 2010-08-03
$9.93M
derived: sum of 3 quarters · filed 2012-02-27
$215.00K
derived: sum of 4 quarters · filed 2012-02-27
2010-03-27-$749.00K
10-Q · filed 2011-05-04
$3.47M
derived: sum of 2 quarters · filed 2012-02-27
-$6.24M
derived: sum of 3 quarters · filed 2012-02-27
2009-12-26$4.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
-$5.49M
derived: sum of 2 quarters · filed 2012-02-27
-$9.54M
10-K · filed 2012-02-27
2009-09-26-$9.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04
-$13.77M
10-Q · filed 2010-11-04
2009-06-27-$4.06M
10-Q · filed 2010-08-03
2008-12-27$1.15M
10-K · filed 2011-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71